Medplus Health Services witnessed a dip in its share price during early trade on December 29, triggered by a drug licence suspension order received by one of its subsidiary companies.
According to the company, the subsidiary received orders from Assistant Director & Drug Sales Licensing Authority and drug control authorities across various locations. The licence suspension order, effective for seven days from the date of receipt, pertains to stores located at Kongareddy Palli, Chittoor District, Andhra Pradesh.
As of the latest update, Medplus Health Services shares were trading at ₹739.95.
